Patients in Guangdong province pay 65438+2000 yuan at their own expense every year, and the rest are funded by medical insurance and China Charity Association.
Gleevec is mainly used to treat chronic leukemia and malignant gastrointestinal stromal tumors. This medicine is produced by Novartis in India and Switzerland. India is a generic drug, which is relatively cheap, while Novartis is a patented drug, which is very expensive.
Application procedure for free Gleevec project
I. Sponsor of Gleevec Project:
1. Urban residents and poor rural households;
2. The registered doctor in the medical center checked that the patient's condition conforms to the indications of Gleevec, that is, chronic myeloid leukemia: acute phase of chronic myeloid leukemia, accelerated phase of chronic myeloid leukemia, and chronic phase of chronic myeloid leukemia with interferon treatment failure (those who still show chromosome positive after using interferon for more than one year); Malignant intestinal stromal tumor: no
Surgical resection of malignant intestinal stromal tumor, surgical resection failed malignant intestinal stromal tumor, metastatic malignant intestinal stromal tumor.